THE ACTIONS OF BOSENTAN, AN ENDOTHELIN RECEPTOR ANTAGONIST, ON CEREBRAL ARTERIOLES IN-SITU

被引：0
|
作者：
PATEL, TR [1 ]
MCAULEY, MA [1 ]
MCCULLOCH, J [1 ]
机构：
[1] UNIV GLASGOW,WELLCOME NEUROSCI GRP,GLASGOW G61 1QH,SCOTLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1994年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：U31 / U31
页数：1
相关论文
共 50 条
  • [41] Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)
    Riccardi, M. T.
    Chiala, A.
    Iannone, F.
    Grattagliano, V.
    Covelli, M.
    Lapadula, G.
    REUMATISMO, 2007, 59 (02) : 135 - 139
  • [42] Investigation of the mutual pharmacokinetic interactions between bosentan, a dual endothelin receptor antagonist, and simvastatin
    Dingemanse, J
    Schaarschmidt, D
    Van Giersbergen, PLM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 547P - 547P
  • [43] Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
    Korn, JH
    Mayes, M
    Cerinic, MM
    Rainisio, M
    Pope, J
    Hachulla, E
    Rich, E
    Carpentier, P
    Molitor, J
    Seibold, JR
    Hsu, V
    Guillevin, L
    Chatterjee, S
    Peter, HH
    Coppock, J
    Herrick, A
    Merkel, PA
    Simms, R
    Denton, CP
    Furst, D
    Nguyen, N
    Gaitonde, M
    Black, C
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 3985 - 3993
  • [44] Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock
    Wanecek, M
    Weitzberg, E
    Alving, K
    Rudehill, A
    Oldner, A
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (10) : 1262 - 1270
  • [45] Influence of food intake and formulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    Bodin, F
    Weidekamm, E
    Kutz, K
    van Giersbergen, P
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (03): : 283 - 289
  • [46] Investigation of the Mutual Pharmacokinetic Interactions Between Bosentan, a Dual Endothelin Receptor Antagonist, and Simvastatin
    Jasper Dingemanse
    Dieter Schaarschmidt
    Paul L. M. van Giersbergen
    Clinical Pharmacokinetics, 2003, 42 : 293 - 301
  • [47] DISTRIBUTION OF ENDOTHELIN RECEPTOR SUBTYPES IN THE RAT-KIDNEY - RENAL AND HEMODYNAMIC-EFFECTS OF THE MIXED (A/B)-ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN
    HOCHER, B
    ROHMEISS, P
    DIEKMANN, F
    ZART, R
    YOGT, V
    SCHILLER, S
    BAUER, C
    KOPPENHAGEN, K
    DISTLER, A
    GRETZ, N
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1995, 33 (08): : 463 - 472
  • [48] Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury
    Kazimoglu, H.
    Uysal, E.
    Dokur, M.
    Gurer, A. O.
    Batcioglu, K.
    Uyumlu, B. A.
    Petekkaya, E.
    Karadag, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (08): : 547 - 553
  • [49] Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis - Acute effects of bosentan, an endothelin receptor antagonist
    Ono, K
    Matsumori, A
    Shioi, T
    Furukawa, Y
    Sasayama, S
    CIRCULATION, 1999, 100 (17) : 1823 - 1829
  • [50] Endothelin receptor mediated constriction and dilatation in feline cerebral resistance arterioles in vivo
    Patel, TR
    McAuley, MA
    McCulloch, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 307 (01) : 41 - 48
12345